Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial Article Swipe
Julien Taı̈eb
,
Dominik Paul Modest
,
Marwan Fakih
,
Fortunato Ciardiello
,
Eric Van Cutsem
,
Elena Élez
,
Cristina Grávalos
,
Arinilda Campos Bragagnoli
,
Valentine Barboux
,
L. Roby
,
Nadia Amellal
,
Gerald W Prager
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.ejca.2025.115644
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.ejca.2025.115644
The survival benefit of treatment with FTD/TPI + bevacizumab versus FTD/TPI is likely associated with the improvement of ETS and DpR.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.ejca.2025.115644
- https://www.ejcancer.com/article/S0959-8049(25)00426-5/pdf
- OA Status
- hybrid
- References
- 19
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4412430962
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4412430962Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.ejca.2025.115644Digital Object Identifier
- Title
-
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trialWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-07-15Full publication date if available
- Authors
-
Julien Taı̈eb, Dominik Paul Modest, Marwan Fakih, Fortunato Ciardiello, Eric Van Cutsem, Elena Élez, Cristina Grávalos, Arinilda Campos Bragagnoli, Valentine Barboux, L. Roby, Nadia Amellal, Gerald W PragerList of authors in order
- Landing page
-
https://doi.org/10.1016/j.ejca.2025.115644Publisher landing page
- PDF URL
-
https://www.ejcancer.com/article/S0959-8049(25)00426-5/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://www.ejcancer.com/article/S0959-8049(25)00426-5/pdfDirect OA link when available
- Concepts
-
Refractory (planetary science), Colorectal cancer, Medicine, Bevacizumab, Oncology, Complete response, Sunlight, Internal medicine, Shrinkage, Cancer, Chemotherapy, Biology, Astronomy, Machine learning, Astrobiology, Computer science, PhysicsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
19Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4412430962 |
|---|---|
| doi | https://doi.org/10.1016/j.ejca.2025.115644 |
| ids.doi | https://doi.org/10.1016/j.ejca.2025.115644 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40694985 |
| ids.openalex | https://openalex.org/W4412430962 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000008 |
| mesh[1].descriptor_ui | D000068258 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | administration & dosage |
| mesh[1].descriptor_name | Bevacizumab |
| mesh[2].qualifier_ui | Q000008 |
| mesh[2].descriptor_ui | D014271 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | administration & dosage |
| mesh[2].descriptor_name | Trifluridine |
| mesh[3].qualifier_ui | Q000009 |
| mesh[3].descriptor_ui | D014271 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | adverse effects |
| mesh[3].descriptor_name | Trifluridine |
| mesh[4].qualifier_ui | Q000188 |
| mesh[4].descriptor_ui | D015179 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | drug therapy |
| mesh[4].descriptor_name | Colorectal Neoplasms |
| mesh[5].qualifier_ui | Q000473 |
| mesh[5].descriptor_ui | D015179 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | pathology |
| mesh[5].descriptor_name | Colorectal Neoplasms |
| mesh[6].qualifier_ui | Q000401 |
| mesh[6].descriptor_ui | D015179 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | mortality |
| mesh[6].descriptor_name | Colorectal Neoplasms |
| mesh[7].qualifier_ui | Q000627 |
| mesh[7].descriptor_ui | D000971 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | therapeutic use |
| mesh[7].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[8].qualifier_ui | Q000009 |
| mesh[8].descriptor_ui | D000971 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | adverse effects |
| mesh[8].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008297 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Male |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D005260 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Female |
| mesh[11].qualifier_ui | Q000008 |
| mesh[11].descriptor_ui | D011759 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | administration & dosage |
| mesh[11].descriptor_name | Pyrrolidines |
| mesh[12].qualifier_ui | Q000008 |
| mesh[12].descriptor_ui | D013941 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | administration & dosage |
| mesh[12].descriptor_name | Thymine |
| mesh[13].qualifier_ui | Q000031 |
| mesh[13].descriptor_ui | D013941 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | analogs & derivatives |
| mesh[13].descriptor_name | Thymine |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000368 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Aged |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D008875 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Middle Aged |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D004338 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Drug Combinations |
| mesh[17].qualifier_ui | Q000187 |
| mesh[17].descriptor_ui | D047368 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | drug effects |
| mesh[17].descriptor_name | Tumor Burden |
| mesh[18].qualifier_ui | Q000031 |
| mesh[18].descriptor_ui | D014498 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | analogs & derivatives |
| mesh[18].descriptor_name | Uracil |
| mesh[19].qualifier_ui | Q000008 |
| mesh[19].descriptor_ui | D014498 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | administration & dosage |
| mesh[19].descriptor_name | Uracil |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D000328 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Adult |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D016896 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Treatment Outcome |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D000369 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Aged, 80 and over |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D009362 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Neoplasm Metastasis |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D006801 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Humans |
| mesh[25].qualifier_ui | Q000008 |
| mesh[25].descriptor_ui | D000068258 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | administration & dosage |
| mesh[25].descriptor_name | Bevacizumab |
| mesh[26].qualifier_ui | Q000008 |
| mesh[26].descriptor_ui | D014271 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | administration & dosage |
| mesh[26].descriptor_name | Trifluridine |
| mesh[27].qualifier_ui | Q000009 |
| mesh[27].descriptor_ui | D014271 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | adverse effects |
| mesh[27].descriptor_name | Trifluridine |
| mesh[28].qualifier_ui | Q000188 |
| mesh[28].descriptor_ui | D015179 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | drug therapy |
| mesh[28].descriptor_name | Colorectal Neoplasms |
| mesh[29].qualifier_ui | Q000473 |
| mesh[29].descriptor_ui | D015179 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | pathology |
| mesh[29].descriptor_name | Colorectal Neoplasms |
| mesh[30].qualifier_ui | Q000401 |
| mesh[30].descriptor_ui | D015179 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | mortality |
| mesh[30].descriptor_name | Colorectal Neoplasms |
| mesh[31].qualifier_ui | Q000627 |
| mesh[31].descriptor_ui | D000971 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | therapeutic use |
| mesh[31].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[32].qualifier_ui | Q000009 |
| mesh[32].descriptor_ui | D000971 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | adverse effects |
| mesh[32].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D008297 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Male |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D005260 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Female |
| mesh[35].qualifier_ui | Q000008 |
| mesh[35].descriptor_ui | D011759 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | administration & dosage |
| mesh[35].descriptor_name | Pyrrolidines |
| mesh[36].qualifier_ui | Q000008 |
| mesh[36].descriptor_ui | D013941 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | administration & dosage |
| mesh[36].descriptor_name | Thymine |
| mesh[37].qualifier_ui | Q000031 |
| mesh[37].descriptor_ui | D013941 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | analogs & derivatives |
| mesh[37].descriptor_name | Thymine |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D000368 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Aged |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D008875 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Middle Aged |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D004338 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Drug Combinations |
| mesh[41].qualifier_ui | Q000187 |
| mesh[41].descriptor_ui | D047368 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | drug effects |
| mesh[41].descriptor_name | Tumor Burden |
| mesh[42].qualifier_ui | Q000031 |
| mesh[42].descriptor_ui | D014498 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | analogs & derivatives |
| mesh[42].descriptor_name | Uracil |
| mesh[43].qualifier_ui | Q000008 |
| mesh[43].descriptor_ui | D014498 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | administration & dosage |
| mesh[43].descriptor_name | Uracil |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D000328 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Adult |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D016896 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Treatment Outcome |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D000369 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Aged, 80 and over |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D009362 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Neoplasm Metastasis |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D006801 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Humans |
| mesh[49].qualifier_ui | Q000008 |
| mesh[49].descriptor_ui | D000068258 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | administration & dosage |
| mesh[49].descriptor_name | Bevacizumab |
| type | article |
| title | Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial |
| biblio.issue | |
| biblio.volume | 227 |
| biblio.last_page | 115644 |
| biblio.first_page | 115644 |
| topics[0].id | https://openalex.org/T11067 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Colorectal Cancer Treatments and Studies |
| topics[1].id | https://openalex.org/T10073 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9979000091552734 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2721 |
| topics[1].subfield.display_name | Hepatology |
| topics[1].display_name | Hepatocellular Carcinoma Treatment and Prognosis |
| topics[2].id | https://openalex.org/T10696 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9979000091552734 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Gastric Cancer Management and Outcomes |
| is_xpac | False |
| apc_list.value | 3800 |
| apc_list.currency | USD |
| apc_list.value_usd | 3800 |
| apc_paid.value | 3800 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3800 |
| concepts[0].id | https://openalex.org/C142424586 |
| concepts[0].level | 2 |
| concepts[0].score | 0.765654981136322 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7307572 |
| concepts[0].display_name | Refractory (planetary science) |
| concepts[1].id | https://openalex.org/C526805850 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7613207101821899 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q188874 |
| concepts[1].display_name | Colorectal cancer |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.744817852973938 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2777802072 |
| concepts[3].level | 3 |
| concepts[3].score | 0.7189443111419678 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q413299 |
| concepts[3].display_name | Bevacizumab |
| concepts[4].id | https://openalex.org/C143998085 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5679291486740112 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[4].display_name | Oncology |
| concepts[5].id | https://openalex.org/C3019096185 |
| concepts[5].level | 3 |
| concepts[5].score | 0.49654680490493774 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1340863 |
| concepts[5].display_name | Complete response |
| concepts[6].id | https://openalex.org/C170853661 |
| concepts[6].level | 2 |
| concepts[6].score | 0.48161906003952026 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q193788 |
| concepts[6].display_name | Sunlight |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.46034693717956543 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C180145272 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4184339642524719 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7504144 |
| concepts[8].display_name | Shrinkage |
| concepts[9].id | https://openalex.org/C121608353 |
| concepts[9].level | 2 |
| concepts[9].score | 0.34435558319091797 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[9].display_name | Cancer |
| concepts[10].id | https://openalex.org/C2776694085 |
| concepts[10].level | 2 |
| concepts[10].score | 0.33425045013427734 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[10].display_name | Chemotherapy |
| concepts[11].id | https://openalex.org/C86803240 |
| concepts[11].level | 0 |
| concepts[11].score | 0.06145504117012024 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[11].display_name | Biology |
| concepts[12].id | https://openalex.org/C1276947 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q333 |
| concepts[12].display_name | Astronomy |
| concepts[13].id | https://openalex.org/C119857082 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q2539 |
| concepts[13].display_name | Machine learning |
| concepts[14].id | https://openalex.org/C87355193 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q411 |
| concepts[14].display_name | Astrobiology |
| concepts[15].id | https://openalex.org/C41008148 |
| concepts[15].level | 0 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[15].display_name | Computer science |
| concepts[16].id | https://openalex.org/C121332964 |
| concepts[16].level | 0 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[16].display_name | Physics |
| keywords[0].id | https://openalex.org/keywords/refractory |
| keywords[0].score | 0.765654981136322 |
| keywords[0].display_name | Refractory (planetary science) |
| keywords[1].id | https://openalex.org/keywords/colorectal-cancer |
| keywords[1].score | 0.7613207101821899 |
| keywords[1].display_name | Colorectal cancer |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.744817852973938 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/bevacizumab |
| keywords[3].score | 0.7189443111419678 |
| keywords[3].display_name | Bevacizumab |
| keywords[4].id | https://openalex.org/keywords/oncology |
| keywords[4].score | 0.5679291486740112 |
| keywords[4].display_name | Oncology |
| keywords[5].id | https://openalex.org/keywords/complete-response |
| keywords[5].score | 0.49654680490493774 |
| keywords[5].display_name | Complete response |
| keywords[6].id | https://openalex.org/keywords/sunlight |
| keywords[6].score | 0.48161906003952026 |
| keywords[6].display_name | Sunlight |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.46034693717956543 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/shrinkage |
| keywords[8].score | 0.4184339642524719 |
| keywords[8].display_name | Shrinkage |
| keywords[9].id | https://openalex.org/keywords/cancer |
| keywords[9].score | 0.34435558319091797 |
| keywords[9].display_name | Cancer |
| keywords[10].id | https://openalex.org/keywords/chemotherapy |
| keywords[10].score | 0.33425045013427734 |
| keywords[10].display_name | Chemotherapy |
| keywords[11].id | https://openalex.org/keywords/biology |
| keywords[11].score | 0.06145504117012024 |
| keywords[11].display_name | Biology |
| language | en |
| locations[0].id | doi:10.1016/j.ejca.2025.115644 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S16731738 |
| locations[0].source.issn | 0959-8049, 1879-0852 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0959-8049 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | European Journal of Cancer |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.ejcancer.com/article/S0959-8049(25)00426-5/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | European Journal of Cancer |
| locations[0].landing_page_url | https://doi.org/10.1016/j.ejca.2025.115644 |
| locations[1].id | pmid:40694985 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | European journal of cancer (Oxford, England : 1990) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40694985 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5024180743 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9955-4753 |
| authorships[0].author.display_name | Julien Taı̈eb |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I39804081, https://openalex.org/I4210091437, https://openalex.org/I4210092322, https://openalex.org/I4210095243, https://openalex.org/I4210097159, https://openalex.org/I4210102325 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Gastroenterology and Gastrointestinal Oncology, CARPEM Comprehensive Cancer Center, Georges-Pompidou European Hospital, AP-HP, Université Paris-Cité, Paris, France; Centre de Recherche des Cordeliers, INSERM, CNRS, Université Paris-Cité, Sorbonne Université, USPC, Equipe Labellisée Ligue Nationale Contre le Cancer, SIRIC CARPEM, Paris, France. Electronic address: [email protected]. |
| authorships[0].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[0].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[0].institutions[1].id | https://openalex.org/I1294671590 |
| authorships[0].institutions[1].ror | https://ror.org/02feahw73 |
| authorships[0].institutions[1].type | government |
| authorships[0].institutions[1].lineage | https://openalex.org/I1294671590 |
| authorships[0].institutions[1].country_code | FR |
| authorships[0].institutions[1].display_name | Centre National de la Recherche Scientifique |
| authorships[0].institutions[2].id | https://openalex.org/I4210092322 |
| authorships[0].institutions[2].ror | https://ror.org/00dmms154 |
| authorships[0].institutions[2].type | facility |
| authorships[0].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I204730241, https://openalex.org/I39804081, https://openalex.org/I4210092322 |
| authorships[0].institutions[2].country_code | FR |
| authorships[0].institutions[2].display_name | Centre de Recherche des Cordeliers |
| authorships[0].institutions[3].id | https://openalex.org/I4210102325 |
| authorships[0].institutions[3].ror | https://ror.org/016vx5156 |
| authorships[0].institutions[3].type | healthcare |
| authorships[0].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210102325, https://openalex.org/I4210120235 |
| authorships[0].institutions[3].country_code | FR |
| authorships[0].institutions[3].display_name | Hôpital Européen Georges-Pompidou |
| authorships[0].institutions[4].id | https://openalex.org/I154526488 |
| authorships[0].institutions[4].ror | https://ror.org/02vjkv261 |
| authorships[0].institutions[4].type | government |
| authorships[0].institutions[4].lineage | https://openalex.org/I154526488 |
| authorships[0].institutions[4].country_code | FR |
| authorships[0].institutions[4].display_name | Inserm |
| authorships[0].institutions[5].id | https://openalex.org/I4210095243 |
| authorships[0].institutions[5].ror | https://ror.org/00rkrv905 |
| authorships[0].institutions[5].type | nonprofit |
| authorships[0].institutions[5].lineage | https://openalex.org/I4210095243 |
| authorships[0].institutions[5].country_code | FR |
| authorships[0].institutions[5].display_name | La Ligue Contre le Cancer |
| authorships[0].institutions[6].id | https://openalex.org/I4210091437 |
| authorships[0].institutions[6].ror | https://ror.org/001z21q04 |
| authorships[0].institutions[6].type | other |
| authorships[0].institutions[6].lineage | https://openalex.org/I4210091437 |
| authorships[0].institutions[6].country_code | FR |
| authorships[0].institutions[6].display_name | Sorbonne Paris Cité |
| authorships[0].institutions[7].id | https://openalex.org/I39804081 |
| authorships[0].institutions[7].ror | https://ror.org/02en5vm52 |
| authorships[0].institutions[7].type | education |
| authorships[0].institutions[7].lineage | https://openalex.org/I39804081 |
| authorships[0].institutions[7].country_code | FR |
| authorships[0].institutions[7].display_name | Sorbonne Université |
| authorships[0].institutions[8].id | https://openalex.org/I204730241 |
| authorships[0].institutions[8].ror | https://ror.org/05f82e368 |
| authorships[0].institutions[8].type | education |
| authorships[0].institutions[8].lineage | https://openalex.org/I204730241 |
| authorships[0].institutions[8].country_code | FR |
| authorships[0].institutions[8].display_name | Université Paris Cité |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Julien Taieb |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Gastroenterology and Gastrointestinal Oncology, CARPEM Comprehensive Cancer Center, Georges-Pompidou European Hospital, AP-HP, Université Paris-Cité, Paris, France; Centre de Recherche des Cordeliers, INSERM, CNRS, Université Paris-Cité, Sorbonne Université, USPC, Equipe Labellisée Ligue Nationale Contre le Cancer, SIRIC CARPEM, Paris, France. Electronic address: [email protected]. |
| authorships[1].author.id | https://openalex.org/A5055766851 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-6853-0599 |
| authorships[1].author.display_name | Dominik Paul Modest |
| authorships[1].countries | DE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I17937529, https://openalex.org/I223822909, https://openalex.org/I7877124 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Hematology, Oncology and Cancer Immunology (CVK), Charité-Universitaetsmedizin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, German Cancer Research Centre (DKFZ), Heidelberg, Germany. |
| authorships[1].institutions[0].id | https://openalex.org/I7877124 |
| authorships[1].institutions[0].ror | https://ror.org/001w7jn25 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I7877124 |
| authorships[1].institutions[0].country_code | DE |
| authorships[1].institutions[0].display_name | Charité - Universitätsmedizin Berlin |
| authorships[1].institutions[1].id | https://openalex.org/I17937529 |
| authorships[1].institutions[1].ror | https://ror.org/04cdgtt98 |
| authorships[1].institutions[1].type | facility |
| authorships[1].institutions[1].lineage | https://openalex.org/I1305996414, https://openalex.org/I17937529 |
| authorships[1].institutions[1].country_code | DE |
| authorships[1].institutions[1].display_name | German Cancer Research Center |
| authorships[1].institutions[2].id | https://openalex.org/I223822909 |
| authorships[1].institutions[2].ror | https://ror.org/038t36y30 |
| authorships[1].institutions[2].type | education |
| authorships[1].institutions[2].lineage | https://openalex.org/I223822909 |
| authorships[1].institutions[2].country_code | DE |
| authorships[1].institutions[2].display_name | Heidelberg University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Dominik P Modest |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Hematology, Oncology and Cancer Immunology (CVK), Charité-Universitaetsmedizin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, German Cancer Research Centre (DKFZ), Heidelberg, Germany. |
| authorships[2].author.id | https://openalex.org/A5061200817 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-6554-5488 |
| authorships[2].author.display_name | Marwan Fakih |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210110459 |
| authorships[2].affiliations[0].raw_affiliation_string | City of Hope Comprehensive Cancer Center, Duarte, USA. |
| authorships[2].institutions[0].id | https://openalex.org/I4210110459 |
| authorships[2].institutions[0].ror | https://ror.org/01z1vct10 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I1301076528, https://openalex.org/I4210110459 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | City of Hope |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Marwan Fakih |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | City of Hope Comprehensive Cancer Center, Duarte, USA. |
| authorships[3].author.id | https://openalex.org/A5043177546 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4661-5540 |
| authorships[3].author.display_name | Fortunato Ciardiello |
| authorships[3].countries | IT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210129624 |
| authorships[3].affiliations[0].raw_affiliation_string | Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy. |
| authorships[3].institutions[0].id | https://openalex.org/I4210129624 |
| authorships[3].institutions[0].ror | https://ror.org/02p9ey581 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210129624 |
| authorships[3].institutions[0].country_code | IT |
| authorships[3].institutions[0].display_name | Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Fortunato Ciardiello |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy. |
| authorships[4].author.id | https://openalex.org/A5090645179 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-6372-1230 |
| authorships[4].author.display_name | Eric Van Cutsem |
| authorships[4].countries | BE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I99464096 |
| authorships[4].affiliations[0].raw_affiliation_string | University Hospitals Gasthuisberg and University of Leuven (KUL), Leuven, Belgium. |
| authorships[4].institutions[0].id | https://openalex.org/I99464096 |
| authorships[4].institutions[0].ror | https://ror.org/05f950310 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I99464096 |
| authorships[4].institutions[0].country_code | BE |
| authorships[4].institutions[0].display_name | KU Leuven |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Eric Van Cutsem |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | University Hospitals Gasthuisberg and University of Leuven (KUL), Leuven, Belgium. |
| authorships[5].author.id | https://openalex.org/A5030657436 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-4653-6324 |
| authorships[5].author.display_name | Elena Élez |
| authorships[5].countries | ES |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I115304662, https://openalex.org/I4210127641 |
| authorships[5].affiliations[0].raw_affiliation_string | Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, Barcelona, Spain. |
| authorships[5].institutions[0].id | https://openalex.org/I115304662 |
| authorships[5].institutions[0].ror | https://ror.org/006zjws59 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I115304662 |
| authorships[5].institutions[0].country_code | ES |
| authorships[5].institutions[0].display_name | Universitat de Vic - Universitat Central de Catalunya |
| authorships[5].institutions[1].id | https://openalex.org/I4210127641 |
| authorships[5].institutions[1].ror | https://ror.org/03ba28x55 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I4210127641 |
| authorships[5].institutions[1].country_code | ES |
| authorships[5].institutions[1].display_name | Vall d'Hebron Hospital Universitari |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Elena Elez |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, Barcelona, Spain. |
| authorships[6].author.id | https://openalex.org/A5050020897 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Cristina Grávalos |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210086614 |
| authorships[6].affiliations[0].raw_affiliation_string | Medical Oncology Department, 12 de Octubre University Hospital, Madrid, Spain. |
| authorships[6].institutions[0].id | https://openalex.org/I4210086614 |
| authorships[6].institutions[0].ror | https://ror.org/002x1sg85 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210086614 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Research Institute Hospital 12 de Octubre |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Cristina Gravalos |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Medical Oncology Department, 12 de Octubre University Hospital, Madrid, Spain. |
| authorships[7].author.id | https://openalex.org/A5032168190 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-5165-0797 |
| authorships[7].author.display_name | Arinilda Campos Bragagnoli |
| authorships[7].countries | BR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210093009 |
| authorships[7].affiliations[0].raw_affiliation_string | Fundacao Pio Xii Hospital Cancer De Barretos, Barretos, Brazil. |
| authorships[7].institutions[0].id | https://openalex.org/I4210093009 |
| authorships[7].institutions[0].ror | https://ror.org/00f2kew86 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210093009 |
| authorships[7].institutions[0].country_code | BR |
| authorships[7].institutions[0].display_name | Hospital de Câncer de Barretos |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Arinilda Campos Bragagnoli |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Fundacao Pio Xii Hospital Cancer De Barretos, Barretos, Brazil. |
| authorships[8].author.id | https://openalex.org/A5064701501 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Valentine Barboux |
| authorships[8].countries | FR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210135308 |
| authorships[8].affiliations[0].raw_affiliation_string | Servier International Research Institute, Suresnes, France. |
| authorships[8].institutions[0].id | https://openalex.org/I4210135308 |
| authorships[8].institutions[0].ror | https://ror.org/034e7c066 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210135308 |
| authorships[8].institutions[0].country_code | FR |
| authorships[8].institutions[0].display_name | Servier (France) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Valentine Barboux |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Servier International Research Institute, Suresnes, France. |
| authorships[9].author.id | https://openalex.org/A5015702523 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | L. Roby |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210135308 |
| authorships[9].affiliations[0].raw_affiliation_string | Servier International Research Institute, Suresnes, France. |
| authorships[9].institutions[0].id | https://openalex.org/I4210135308 |
| authorships[9].institutions[0].ror | https://ror.org/034e7c066 |
| authorships[9].institutions[0].type | company |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210135308 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Servier (France) |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Lucas Roby |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Servier International Research Institute, Suresnes, France. |
| authorships[10].author.id | https://openalex.org/A5062974425 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-6171-6729 |
| authorships[10].author.display_name | Nadia Amellal |
| authorships[10].countries | FR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210135308 |
| authorships[10].affiliations[0].raw_affiliation_string | Servier International Research Institute, Suresnes, France. |
| authorships[10].institutions[0].id | https://openalex.org/I4210135308 |
| authorships[10].institutions[0].ror | https://ror.org/034e7c066 |
| authorships[10].institutions[0].type | company |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210135308 |
| authorships[10].institutions[0].country_code | FR |
| authorships[10].institutions[0].display_name | Servier (France) |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Nadia Amellal |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Servier International Research Institute, Suresnes, France. |
| authorships[11].author.id | https://openalex.org/A5113235514 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Gerald W Prager |
| authorships[11].countries | AT |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I76134821 |
| authorships[11].affiliations[0].raw_affiliation_string | Medical University Vienna, Vienna, Austria. |
| authorships[11].institutions[0].id | https://openalex.org/I76134821 |
| authorships[11].institutions[0].ror | https://ror.org/05n3x4p02 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I76134821 |
| authorships[11].institutions[0].country_code | AT |
| authorships[11].institutions[0].display_name | Medical University of Vienna |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Gerald W Prager |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Medical University Vienna, Vienna, Austria. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ejcancer.com/article/S0959-8049(25)00426-5/pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11067 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Colorectal Cancer Treatments and Studies |
| related_works | https://openalex.org/W3142026086, https://openalex.org/W2391958761, https://openalex.org/W2765453142, https://openalex.org/W2356780078, https://openalex.org/W2356008845, https://openalex.org/W255134961, https://openalex.org/W2348314720, https://openalex.org/W2243547089, https://openalex.org/W2316482937, https://openalex.org/W2253986335 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.ejca.2025.115644 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S16731738 |
| best_oa_location.source.issn | 0959-8049, 1879-0852 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0959-8049 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | European Journal of Cancer |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.ejcancer.com/article/S0959-8049(25)00426-5/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | European Journal of Cancer |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.ejca.2025.115644 |
| primary_location.id | doi:10.1016/j.ejca.2025.115644 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S16731738 |
| primary_location.source.issn | 0959-8049, 1879-0852 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0959-8049 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | European Journal of Cancer |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.ejcancer.com/article/S0959-8049(25)00426-5/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | European Journal of Cancer |
| primary_location.landing_page_url | https://doi.org/10.1016/j.ejca.2025.115644 |
| publication_date | 2025-07-15 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4367835002, https://openalex.org/W2019607817, https://openalex.org/W2992695196, https://openalex.org/W2162396679, https://openalex.org/W2005348280, https://openalex.org/W2509067245, https://openalex.org/W2104804192, https://openalex.org/W3135613632, https://openalex.org/W1933451634, https://openalex.org/W3128337346, https://openalex.org/W2167571044, https://openalex.org/W2060189595, https://openalex.org/W2911902197, https://openalex.org/W2118571739, https://openalex.org/W2051315590, https://openalex.org/W2095201384, https://openalex.org/W2765766854, https://openalex.org/W2165385913, https://openalex.org/W1633683275 |
| referenced_works_count | 19 |
| abstract_inverted_index.+ | 7 |
| abstract_inverted_index.is | 11 |
| abstract_inverted_index.of | 3, 17 |
| abstract_inverted_index.ETS | 18 |
| abstract_inverted_index.The | 0 |
| abstract_inverted_index.and | 19 |
| abstract_inverted_index.the | 15 |
| abstract_inverted_index.DpR. | 20 |
| abstract_inverted_index.with | 5, 14 |
| abstract_inverted_index.likely | 12 |
| abstract_inverted_index.versus | 9 |
| abstract_inverted_index.FTD/TPI | 6, 10 |
| abstract_inverted_index.benefit | 2 |
| abstract_inverted_index.survival | 1 |
| abstract_inverted_index.treatment | 4 |
| abstract_inverted_index.associated | 13 |
| abstract_inverted_index.bevacizumab | 8 |
| abstract_inverted_index.improvement | 16 |
| cited_by_percentile_year | |
| countries_distinct_count | 8 |
| institutions_distinct_count | 12 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.47999998927116394 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| sustainable_development_goals[1].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[1].score | 0.4000000059604645 |
| sustainable_development_goals[1].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.40563058 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |